Tamarind Bio
PrivateLast Round
Series A
Feb 26, 2026
Total Funding Raised
$27.2M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Tamarind Bio is a biotechnology company that develops a no-code computational platform and API for drug discovery, enabling researchers to deploy and run bioinformatics models without managing complex infrastructure.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Workflow Automation, Drug Discovery, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tamarind Bio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Tamarind Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 26, 2026 | ||||
| Series A | May 15, 2025 | ||||
| Seed | Jan 1, 2024 |
Key People
Founding team and executive leadership
Tamarind Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dimension | Series A |
| Treeo VC | Series A |
| Phosphor Capital | Series A |
| Y Combinator | Seed, Series A |
| Dimension | Series A |
| 468 Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2026
Grew 73% QoQ, from 11 to 19 employees.
- Apr 2, 2026
Streamlines experimental validation for AI-enabled antibody discovery.
Tamarind Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tamarind Bio's valuation, stock price, and market status.